Australia’s medicines regulator the Therapeutic Goods Administration (TGA) has introduced a streamlined way for sponsors to submit adverse event reports for medicines and vaccines, to ease the administrative burden of the 7,000–8,000 annual reports.
The TGA says the streamlining will make it easier to meet mandatory reporting requirements, reduce manual data entry and double-handling, as well as the potential for errors.
Sponsors will now be able to submit adverse event reports via email, using the widely-used international “E2B” standard. Data supplied in this format can be entered directly into the TGA's adverse event database with minimal user interaction.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze